1. Home
  2. LUNG vs RLTY Comparison

LUNG vs RLTY Comparison

Compare LUNG & RLTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • RLTY
  • Stock Information
  • Founded
  • LUNG 1995
  • RLTY 2022
  • Country
  • LUNG United States
  • RLTY United States
  • Employees
  • LUNG N/A
  • RLTY N/A
  • Industry
  • LUNG Industrial Specialties
  • RLTY Investment Managers
  • Sector
  • LUNG Health Care
  • RLTY Finance
  • Exchange
  • LUNG Nasdaq
  • RLTY Nasdaq
  • Market Cap
  • LUNG 248.0M
  • RLTY 256.4M
  • IPO Year
  • LUNG 2020
  • RLTY N/A
  • Fundamental
  • Price
  • LUNG $7.30
  • RLTY $16.32
  • Analyst Decision
  • LUNG Strong Buy
  • RLTY
  • Analyst Count
  • LUNG 7
  • RLTY 0
  • Target Price
  • LUNG $13.71
  • RLTY N/A
  • AVG Volume (30 Days)
  • LUNG 237.6K
  • RLTY 86.7K
  • Earning Date
  • LUNG 10-28-2024
  • RLTY 01-01-0001
  • Dividend Yield
  • LUNG N/A
  • RLTY 9.35%
  • EPS Growth
  • LUNG N/A
  • RLTY N/A
  • EPS
  • LUNG N/A
  • RLTY N/A
  • Revenue
  • LUNG $76,583,000.00
  • RLTY N/A
  • Revenue This Year
  • LUNG $22.73
  • RLTY N/A
  • Revenue Next Year
  • LUNG $19.02
  • RLTY N/A
  • P/E Ratio
  • LUNG N/A
  • RLTY N/A
  • Revenue Growth
  • LUNG 26.26
  • RLTY N/A
  • 52 Week Low
  • LUNG $5.46
  • RLTY $11.38
  • 52 Week High
  • LUNG $14.84
  • RLTY $14.60
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 41.60
  • RLTY 41.86
  • Support Level
  • LUNG $7.18
  • RLTY $16.72
  • Resistance Level
  • LUNG $8.59
  • RLTY $17.28
  • Average True Range (ATR)
  • LUNG 0.40
  • RLTY 0.35
  • MACD
  • LUNG -0.16
  • RLTY -0.15
  • Stochastic Oscillator
  • LUNG 7.74
  • RLTY 5.87

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About RLTY Cohen & Steers Real Estate Opportunities and Income Fund of Beneficial Interest

Cohen & Steers Real Estate Opportunities and Income Fund is an organized, non-diversified, closed-end management investment company. The Fund's primary investment objective is high current income. The Fund's secondary investment objective is capital appreciation.

Share on Social Networks: